In heart failure secondary to chronic mechanical overload, cardiac sympathetic neurons demonstrate depressed catecholamine synthetic and transport function. To assess the potential of sympathetic neuronal imaging for detection of depressed transport function, serial scintigrams were acquired after the intravenous administration of metaiodobenzylguanidine ['"I] to 13 normal dogs, 3 autotransplanted (denervated) dogs, 5 dogs with left ventricular failure, and 5 dogs with compensated left ventricular hypertrophy due to a surgical arteriovenous shunt. Nine dogs were killed at 14 hours postinjection for determination of metaiodobenzylguanidine [ I3 'I] and endogenous norepinephrine content in left atrium, left ventricle, liver, and spleen. By 4 hours postinjection, autotransplanted dogs had a 39% reduction in mean left ventricular tracer accumulation, reflecting an absent intraneuronal tracer pool. Failure dogs demonstrated an accelerated early mean left ventricular tracer efflux rate (26.0%/hour versus 13.7%/hour in normals), reflecting a disproportionately increased extraneuronal tracer pool. They also showed reduced late left ventricular and left atrial concentrations of tracer, consistent with a reduced intraneuronal tracer pool. By contrast, compensated hypertrophy dogs demonstrated a normal early mean left ventricular tracer efflux rate (16.4%/hour) and essentially normal late left ventricular and left atrial concentrations of tracer. Metaiodobenzylguanidine [ IM I] scintigraphic findings reflect the integrity of the cardiac sympathetic neuronal transport system in canine mechanical-overload heart failure. Metaiodobenzylguanidine [ 123 I] scintigraphy should be explored as a means of early detection of mechanical-overload heart failure in patients. (Circulation Research 1987;61:797-804) H eart failure secondary to mechanical overload is associated with myocardial catecholamine depletion.' Reduced tyrosine hydroxylase activity in the fail ing ventricle 2 lends support to the theory that synthetic function of cardiac sympathetic nerve endings is impaired in mechanical-overload heart failure. Recently, studies from our institution have shown that the catecholamine transport function of cardiac sympathetic nerve endings is also depressed in this form of heart failure. 3 -4 This derangement was specific to the heart and not the result of a generalized depression of the peripheral sympathetic nervous system. 3 It was hypothesized that the above finding of impaired myocardial catecholamine transport could form the basis of a test for early heart failure if it could be shown that the nerves are affected early in the disease and if a suitable imaging agent could be found that is
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In heart failure secondary to chronic mechanical overload, cardiac sympathetic neurons demonstrate depressed catecholamine synthetic and transport function. To assess the potential of sympathetic neuronal imaging for detection of depressed transport function, serial scintigrams were acquired after the intravenous administration of metaiodobenzylguanidine ['"I] to 13 normal dogs, 3 autotransplanted (denervated) dogs, 5 dogs with left ventricular failure, and 5 dogs with compensated left ventricular hypertrophy due to a surgical arteriovenous shunt. Nine dogs were killed at 14 hours postinjection for determination of metaiodobenzylguanidine [ I3 'I] and endogenous norepinephrine content in left atrium, left ventricle, liver, and spleen. By 4 hours postinjection, autotransplanted dogs had a 39% reduction in mean left ventricular tracer accumulation, reflecting an absent intraneuronal tracer pool. Failure dogs demonstrated an accelerated early mean left ventricular tracer efflux rate (26.0%/hour versus 13.7%/hour in normals), reflecting a disproportionately increased extraneuronal tracer pool. They also showed reduced late left ventricular and left atrial concentrations of tracer, consistent with a reduced intraneuronal tracer pool. By contrast, compensated hypertrophy dogs demonstrated a normal early mean left ventricular tracer efflux rate ( H eart failure secondary to mechanical overload is associated with myocardial catecholamine depletion.' Reduced tyrosine hydroxylase activity in the fail ing ventricle 2 lends support to the theory that synthetic function of cardiac sympathetic nerve endings is impaired in mechanical-overload heart failure. Recently, studies from our institution have shown that the catecholamine transport function of cardiac sympathetic nerve endings is also depressed in this form of heart failure. 3 -4 This derangement was specific to the heart and not the result of a generalized depression of the peripheral sympathetic nervous system. 3 It was hypothesized that the above finding of impaired myocardial catecholamine transport could form the basis of a test for early heart failure if it could be shown that the nerves are affected early in the disease and if a suitable imaging agent could be found that is taken up by the same axonal transport system as norepinephrine. The guanethidine analogue, radioiodinated metaiodobenzylguanidine (MIBG), has been shown to compete for the same energy-requiring uptake system (uptake-1) that transports norepinephrine into sympathetic nerve endings. 5 -6 Inhibition of vesicular uptake by reserpine blocked 50% of the total myocardial accumulation of MIBG in rats. 7 The same dosage of reserpine resulted in 90% depletion of endogenous myocardial catecholamines. 8 Chemical sympathectomy with 6-hydroxydopamine caused a 54% reduction in the myocardial accumulation of MIBG [ 125 I] and an 88% reduction in the myocardial accumulation of norepinephrine in rats. 9 The above studies suggest that while MIBG shares the same myocardial neuronal uptake and storage mechanisms with norepinephrine, it binds to extraneuronal tissue in the heart (uptake-2) to a much larger degree than norepinephrine. This binding would appear to be a major drawback to its utility in mapping myocardial sympathetic neuronal function. However, it was surmised that measurement of myocardial MIBG kinetics through serial imaging might still give important insights into myocardial adrenergic neuronal function in disease. For example, in cardiac failure, where neuronal uptake function is depressed, an even greater proportion of MIBG should initially enter the extraneuronal pool. Since MIBG efflux from the extraneuronal compartment is much faster than the highly retentive intraneuronal compartment, 7 adrenergic neuronal dysfunction in cardiac failure might well be characterized by an overall acceleration of measured myocardial MIBG efflux. In fact, rapid clearance of MIBG [ 13I I] from the heart was recently reported in 3 patients with generalized adrenergic dysfunction, 1 with multiple system atrophy, and 2 with Shy-Drager syndrome. 10 Since MIBG is not a catecholamine, it is not expected to be a substrate for monoamine oxidase or catechol-O-methyltransferase." In fact, in patient studies, MIBG was found to be excreted in the urine largely as the unaltered compound. 12 In vivo deiodination of the compound does not occur to any appreciable degree. 12 These results indicate that MIBG [ 131 I] and not free iodine or a metabolite would be responsible for cardiac scintigrams acquired in the hours and days following its intravenous injection.
For these reasons, it was decided to test the hypoth-. esis that serial MIBG [ I3I I] myocardial scintigraphy could detect sympathetic neuronal degeneration in a dog model of mechanical-overload heart failure.
Materials and Methods

Animals Studied
Thirty chronic mongrel dogs, weighing 20-38 kg (mean = 28 kg), were studied: 17 normal dogs, 3 dogs approximately 1 month postcardiac autotransplantation, 13 and 10 dogs postsurgical infrarenal aortocaval arteriovenous shunt. 14 Each of the mechanically overloaded dogs was followed from the time of shunt creation for the development of left ventricular failure, characterized by ascites, weight gain, and easy fatigability (3-19 months). Five dogs developed clinically overt left ventricular failure. The 5 dogs that did not develop the above signs or symptoms were considered to have compensated left ventricular hypertrophy. To objectify this subgrouping further, the treadmill exercise performances of 4 left ventricular failure dogs and 4 compensated left ventricular hypertrophy dogs were assessed 1 week prior to imaging. The treadmill protocol consisted of 3-minute stages at a fixed speed of 2 mph and incremental grades of 0%, 10%, 20%, 30%, 40%, and back to 0%. Heart rate was monitored by electrocardiogram, and blood was drawn for catecholamines via an indwelling catheter in the cephalic vein of the left forepaw. Heart rate and plasma norepinephrine were measured prior to exercise and during the last 30 seconds of each treadmill stage. Norepinephrine plasma concentrations (in picograms per milliliter) were determined in duplicate by radioenzymatic assay (Cat-a-kit, The Upjohn Company, Kalamazoo, Mich.). 15 The heart rate and plasma norepinephrine responses of the left ventricular failure and compensated left ventricular hypertrophy dogs were compared with a group of 11 normal dogs that had undergone the identical exercise protocol.
Radionuclide Imaging
The MIBG [ 131 I], obtained from the University of Alberta Radiopharmaceutical Centre, had a specific activity of 0.2-0.5 mg/mCi. A large field-of-view gamma camera was equipped with a high-energy parallel-hole collimator, utilizing a 20% window around the 360 keV photopeak of m I . On each imaging day, a 5-minute room background count was followed by a 2-minute count of a 100-150 /xd I3I I point source. From these counts, camera sensitivity was computed in counts per microcurie per minute. The camera sensitivity correction factor for a given imaging day was calculated as the ratio of the camera sensitivity on that day to the average camera sensitivity for the entire experiment.
For radionuclide imaging, each dog was anesthetized with intravenous pentobarbital (25 mg/kg). MIBG [ 13I I] scintigraphy was performed in 13 normal dogs, each of the 3 autotransplanted, and each of the 10 mechanically overloaded dogs. After injecting 1.5 mCi intravenously, serial images were acquired in the anterior projection in 128 X 128 format with a 2: 1 software zoom. On day 1, 20-minute duration images were acquired at 0.5, 2, and 4 hours after tracer injection, and on day 2, 50-minute images were acquired at 13 hours after tracer injection in 9 normal dogs, 2 autotransplanted dogs, and 8 mechanically overloaded dogs. One autotransplanted dog and 2 mechanically overloaded dogs underwent 60-minute imaging at 24 hours post-tracer injection.
Radionuclide Imaging Analysis
MIBG [ 13I I] scintigrams were first subjected to 9-point weighted smoothing. Next, 5 x 5 pixel regions of interest were positioned over the left ventricular inferoseptal and lateral walls and 10 x 10 pixel regions of interest over both lobes of the liver. Counts were decay-corrected and normalized to the size of the left ventricular regions of interest, dose of radioactivity administered, and weight of the dog. Left ventricular counts were expressed as the mean of the inferoseptal and lateral walls and liver counts as the mean of the 2 lobes. Left ventricular and hepatic efflux rates, defined as the percent per hour decline in organ region of interest counts, were calculated bet ween 0.5 and 2 hours, 2 hours and 4 hours, and, where available, 4 hours and 13 hours. Left ventricular to hepatic accumulation ratios were computed at 0.5,2,4, and 13 hours post-tracer injection. Also, left ventricular counts were corrected for camera sensitivity to derive a left ventricular accumulation index at the same points in time.
To assess the reproducibility of our image analysis procedure, two observers (M.A.R. and L.L.) independently analyzed 8 of the dog studies. One observer (L.L.) was blind to the physiologic state of each animal. Of the 8 dogs, 5 were normal, 2 were mechanically overloaded, and 1 was autotransplanted.
Tissue Assay for Endogenous Norepinephrine and MIBG [ m I]
Ten dogs, 5 normal and 5 mechanically overloaded, were killed for the purpose of organ tissue assay for endogenous norepinephrine and MIBG [ I3I I] at 14 hours post-tracer injection. Just at the time of intravenous administration of a lethal dose of pentobarbital, the entire heart and pieces of liver and spleen were excised and immediately placed in an ice bath. Next, 0.5-g aliquots obtained from the left ventricular septum and laterals walls, left atrium, liver, and spleen were homogenized and ultracentrifuged to produce a clear supernatant, and 1-ml subaliquots were placed in a gamma well counter that had been calibrated on the same day for ['"I]. After decay-correcting and normalizing for the dose administered and weight of the dog, MIBG [ I3 'I] tissue concentrations in percent kg-dose/g tissue were obtained. 16 The remainder of each of the supernatants was frozen for later norepinephrine assay. Norepinephrine concentrations in micrograms per gram of wet tissue weight for each organ sample were determined by radioenzymatic assay (Cat-a-kit). 15 
Statistical Analysis
The mean±SD of every scintigraphic, plasma, organ tissue, and heart rate determination was calculated for each group of dogs. Because of the small sample sizes involved, the nonparametric Wilcoxon statistic was used to test the significance of differences between the distributions for the normal dogs and for each of the abnormal groups: autotransplanted (denervated), mechanically overloaded with compensated left ventricular hypertrophy, and mechanically overloaded with left ventricular failure. To avoid the problem of increasing experimentwise type I errors, a strict/? value of sO.Ol was considered to be significant.
For the interobserver variability study, a coefficient of linear correlation (r) between the results of observer 1 and observer 2 was calculated for each scintigraphic index, and a t ratio andp value were computed for each r value.
Results The mean left ventricular weights of the 5 failure dogs (173 ± 4 5 g) and the 5 compensated hypertrophy dogs (176 ± 2 3 g) were both significantly higher than the normal dog mean (94 ± 24 g based on 50 controls). Table 1 compares the treadmill exercise performance characteristics of 11 normal dogs, 4 compensated left ventricular hypertrophy dogs, and 4 left ventricular failure dogs. There was a tendency for left ventricular failure dogs to have a higher mean heart rate at rest, submaximal exercise, and recovery than the normal controls. Also, left ventricular failure dogs tended to have a higher mean resting plasma norepinephrine than normals. At each exercise stage and recovery, left ventricular failure dogs had significantly higher plasma norepinephrine than the normal group. Compensated left ventricular hypertrophy dogs showed no tendency toward higher mean heart rate or plasma norepinephrine at rest, submaximal exercise, and recovery in comparison with normal controls.
The MIBG [ I3I I] uptake-efflux indexes of the normal and abnormal groups of dogs are given in Table 2 . Four indexes are tabulated. Left ventricular efflux rate and hepatic efflux rate are given for each of 3 time intervals. The ratio of left ventricular to hepatic accumulation and the left ventricular accumulation index are given at each of 4 points in time. In the normal dogs, the efflux of MIBG [ 131 I] from the left ventricular myocardium was fastest between 30 minutes and 2 hours postinjection (13.7%/hr). Left ventricular efflux rate was almost as fast over the ensuing 2 hours (12.5%/hr). It slowed to 5.7%/hr between 4 and 13 hours postinjection. Hepatic efflux rate was slightly faster than left ventricular efflux rate over each of the time intervals. Consequently, the left ventricular to hepatic accumulation ratio, 0.93 at 30 minutes, progressively rose to 0.99 by 2 hours, 1.10 by 4 hours, and 1.23 by 13 hours postinjection. The autotransplanted (denervated) dogs tended to have a reduced left ventricular to hepatic accumulation ratio and a reduced left ventricular accumulation index at 0.5 hours. They also tended to have accelerated 0.5to 2-hour left ventricular efflux rates (mean = 20.3%/ hr). Because of the small sample size, statistical significance was not achieved. However, at 2 and 4 hours post-tracer injection, these dogs had significantly depressed mean left ventricular to hepatic accumulation ratios (0.67 and 0.65), as well as reduced left ventricular accumulation indexes (37 and 39% below normal).
The left ventricular failure dogs had an increased mean 0.5-to 2-hour left ventricular efflux rate of 26%/hr, which was highly significant. Their mean hepatic efflux rate over the same time interval was not significantly different from the normal group. These dogs had a significantly increased mean 0.5-hour left ventricular to hepatic accumulation ratio of 1.42. They tended to have decreased 4-and 13-hour left ventricular to hepatic accumulation ratios. However, again because of the small sample size, statistical significance was not reached for these latter 2 points in time.
In contrast to the left ventricular failure dogs, compensated left ventricular hypertrophy dogs showed no difference in their mean 0.5-to 2-hour left ventricular efflux rate (16.4%/hr) from the normal group. The compensated left ventricular hypertrophy dogs had a significantly elevated mean 0.5-hour left ventricular to hepatic accumulation ratio of 1.24. However, unlike the left ventricular failure dogs, these dogs showed no tendency toward a depressed mean ratio over the ensuing 13 hours. Figure 1 shows the early (0.5 hour) and delayed (13 hour) MIBG [ 131 I] smoothed scintigrams of a representative normal, autotransplanted, and left ventricular failure dog. The early images were acquired for 20 minutes, while the delayed images were acquired for 50 minutes. In the normal dogs, there is excellent initial myocardial accumulation, approaching that of the liver, at 0.5 hours (left). In the 13-hour image on the right, myocardial retention exceeds that of the liver. In addition, the atrium and spleen are clearly visible on the delayed 13-hour image. The autotransplanted dog shows relatively poor initial accumulation of MIBG [ I3I I]. By 13 hours, the heart (atria and ventricles) is practically invisible, whereas splenic accumulation of tracer is excellent. The dog with left ventricular failure shows initially excellent myocardial accumulation, exceeding that of the liver, but by 13 hours, the heart (atria and ventricles) is poorly visible. At the same time, the spleen of this dog is quite apparent on the delayed 13-hour image. The MIBG [ I3I I] organ tissue concentrations at 14 hours post-tracer injection in 10 dogs are given in Table  3 . Each of the left ventricular hypertrophy dogs had a normal mean tracer concentration in the left ventricle. Both left ventricular failure dogs had a depressed mean tracer concentration in this chamber. Each left ventricular hypertrophy dog had a normal left atrial tracer concentration. Both left ventricular failure dogs had severely depressed left atrial tracer concentrations. One left ventricular hypertrophy dog had mildly depressed splenic concentrations of MIBG [ 13I I]. In addition, one of the left ventricular failure dogs had mildly depressed hepatic and moderately depressed splenic concentrations of tracer. Figure 3 plots the relation between MIBG [ I3 'I] and endogenous norepinephrine concentration in 50 organtissue samples from 10 dogs obtained 14 hours after tracer injection. The correlation coefficient is 0.73 (p<0.001). In 2 splenic samples with the highest endogenous norepinephrine contents (5,418 and 9,058 ng/g wet tissue weight), measured MIBG [ I3 'I] concentrations were high (0.25 and 0.29% kg-dose/g) but not in proportion to norepinephrine content.
The interobserver variability results of our imaging analysis procedure are given in Table 4 . The two observers' results were very highly correlated for 13 of 14 quantitative measurements. The only less highly correlated determination was the 4-to 13-hour hepatic efflux rate (r = 0.78, p<0.05). This index does not account for the variability of photon attenuation or left ventricular mass between animals. As a complementary index, a left ventricular to hepatic accumulation ratio was calculated. Our rationale for this index is that for disease processes that specifically affect myocardial adrenergic function, the liver can serve as an internal control. With both indexes, a mild reduction in the initial myocardial accumulation of ] into a rapidly effluxing extraneuronal pool in these animals. 710 A marked slowing of MIBG [ I3 'I] clearance from the myocardium of normal dogs was observed beyond 4 hours after its injection. This is believed to be a reflection of a proportionately greater accumulation of tracer in a highly retentive intraneuronal pool at 4 hours. This interpretation is consistent with previous reserpine-blocking studies in rats, which indicated that at 4 hours after the intravenous injection of tracer, 50% of cardiac MIBG [ I3I I] was located intravesicularly. 7 It may be questioned why, if a neuronal pool were absent in the autotransplanted dogs, did the rate of MIBG [ I31 I] efflux slow down to rates comparable with normal dogs between 4 and 13 hours post-tracer injection, this slowing was probably due to the fact that low myocardial counts, approaching those of lung background, resulted in poor counting statistics during these times.
The delayed appearance of the left atrium and spleen •All values are expressed in percent kg-dose/g. tValues in parentheses are Z scores (number of standard deviations beyond the normal mean) exceeding | 2.0 | . Sept = septum; Plat = posterolateral; hypert = hypertrophy.
in the normal dogs on the 13-hour MIBG [ 13I I] images is consistent with the adrenergic neuronal concentration of this tracer. The atrium is known to possess an approximately 3 times greater amount of norepinephrine per gram of tissue than the left ventricle, 17 and the spleen is an organ that is known to possess a dense sympathetic innervation. ' 8 The liver, on the other hand, is an organ with less sympathetic innervation' 9 that serves as a major site for catecholamine degradation. The high initial uptake of MIBG [ 131 I] by the liver in the normal and autotransplanted dogs, followed by relatively rapid efflux, supports a relatively large extraneuronal pool in this organ.
The interpretation in the present study of the serial MIBG [ 13I I] scintigraphic findings in the normal and autotransplanted dogs is supported by the correlative data on MIBG [ I3 'I] and endogenous norepinephrine tissue concentration at 14 hours after tracer injection. Despite the potential for error in the radioenzymatic assay of tissue norepinephrine and in the normalization of MIBG [ I3I I] gamma counts for counter efficiency, dog weight, and dose administered, the good correlation coefficient (0.73) obtained indicates that MIBG [ 13I I] tends to concentrate in various organs in proportion to their endogenous norepinephrine content. In the two splenic samples with the highest endogenous norepinephrine content, MIBG [ 13I I] concentrations were high but not in proportion to norepinephrine content. This finding raises the question of whether the neuronal sites for MIBG [ I3I I] uptake were saturated at these levels (-0.3% kg dose/g). This possibility is considered unlikely since the dose of 0.5 mg of MIBG injected would give a tissue MIBG concentration of only 0.075 /ug/g in the splenic samples. A previous study showed that guanethidine concentration at specific neuronal binding sites reached saturation at 3 /Ag/g in rat heart. 20 Excellent initial myocardial uptake of MIBG [ I3 'I] was observed in all of our mechanically overloaded dogs. All had left ventricular to hepatic uptake ratios at 0.5 hours exceeding 1. This result is explained by the increased mass of left ventricular myocardium that was present in each of these dogs. In two-dimensional planar imaging, each pixel "sees" a greater mass of left ventricular myocardium containing MIBG [ 131 I]. In the left ventricular failure subgroup, the significantly accelerated rate of efflux of tracer between 0.5 and 2 hours postinjection with the consequent fall in the left ventricular to hepatic accumulation ratio to below 1.0 at 4 and 13 hours post-tracer injection is a reflection of the almost exclusive initial uptake of tracer into a rapidly effluxing extraneuronal pool, much like the situation in the autotransplanted dog. Also, the absence of atrial accumulation is consistent with a state of impaired adrenergic neuronal transport function in these animals.
By contrast, the normal early left ventricular efflux rate and normal late left ventricular and atrial retention of tracer in dogs with compensated left ventricular hypertrophy imply intact adrenergic neuronal transport function in these animals. One might put forward the argument that the altered tracer kinetics observed in the left ventricular failure dogs was due to an increased left ventricular muscle mass and, consequently, enlarged extraneuronal pool of tracer. This explanation cannot account for the normal MIBG [ I3 'I] efflux rates observed in the compensated left ventricular hypertrophy dogs. These dogs had an increased mean left ventricular weight (176 ± 2 3 g) comparable to that of their left ventricular failure counterparts (173 ± 4 5 g). The 14-hour post-tracer injection biopsy data (Table 3 ) lend further support to our interpretation of the scintigraphic findings in the mechanically overloaded dogs. At that time, left ventricular concentration of MIBG [ m I] was depressed, and left atrial concentration was severely depressed in the left ventricular failure dogs. In contrast, left ventricular and left atrial concentrations of MIBG [ I3I I] in the compensated left ventricular hypertrophy dogs were essentially normal.
It is possible that competitive inhibition by high circulating endogenous catecholamines may have contributed to the poor cardiac adrenergic neuronal uptake of MIBG [ 131 I] in the left ventricular failure dogs. However, cardiac samples from left ventricular failure dogs had the lowest MIBG [ I3I I] and norepinephrine concentrations of all dogs studied. Therefore, it is our contention that a primary defect in the cardiac sympathetic neuronal uptake system, rather than competitive inhibition, was responsible for the impaired cardiac sequestration of MIBG [ 131 I].
The present study documents the serial MIBG [ 13I I] scintigraphic findings in normal dogs, denervated dogs due to autotransplantation, and mechanically overloaded dogs, both at a stage of compensated left ventricular hypertrophy and a stage of overt left ventricular failure. Clearly, MIBG [ m I] scintigraphic findings do reflect the integrity of the cardiac adren-ergic neuronal system. As yet, the timing of adrennergic transport dysfunction or MIBG [ I3 'I] scintigraphic abnormalities in relation to the development of cardiac failure has not been determined. Quantifiable imaging deterioration must be demonstrable early in the course of the disease if this noninvasive technique is to be clinically useful for the detection of chronic mechanical-overload failure in patients. The use of MIBG [ 123 I] with its shorter half-life and superior dosimetry and imaging characteristics will be required. 21 The use of single-photon emission computed tomography will minimize overlapping and underlying background from neighboring organs. In addition, single-photon emission computed tomography will offer the potential for absolute quantification of tracer accumulation in percent dose per unit volume of tissue. It may also enable the calculation of an accurate delayed atrial MIBG [ 123 I] uptake index.
The documentation of, at most, a 39% reduction in MIBG [ 131 I] myocardial accumulation in autotransplanted dogs in this study reflects the considerable nonspecific myocardial uptake of this tracer. It would be desirable to work with a radiolabelled compound with greater neuronal specificity than MIBG. Until one is found, it will be useful to study various pharmacologic means of minimizing extraneuronal uptake of MIBG. Clonidine, which inhibits extraneuronal myocardial uptake of catecholamines in lower species, 22 should be studied in this regard. Additionally, clonidine pretreatment would reduce the level of circulating catecholamines to basal levels 23 and would remove circulating catecholamine levels as a confounding variable in the interpretation of clinical studies.
